A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

Clinical trial NCT06854341 · COMPLETED

Trial details

NCT number: NCT06854341
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2024-02-09
Primary completion: 2024-08-27
Enrollment: 5448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.